Full Press Release Details
11 Hamenofim St., Building B, Herzliya 4672562,
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON JUNE 21, 2022
________________________
Dear NeuroSense Therapeutics Ltd. Shareholders:
We cordially invite you to
attend an Annual General Meeting of Shareholders (the "Meeting"), of NeuroSense Therapeutics Ltd. (the "Company"),
to be held at 11:00 a.m. (Israel time) on June 21, 2022 at our offices at 11 Hamenofim St., Building B, Herzliya 4672562, Israel.
The Meeting is being called
for the following purposes:
The Company is currently unaware
of any other matters that may be raised at the Meeting. Should any other matters be properly raised at the Meeting, the persons designated
as proxies shall vote according to their own judgment on those matters. Our Board of Directors unanimously recommends that you vote in
favor of the above proposal, which will be described in the Proxy Statement to be provided separately.
Shareholders of record at the
close of business on May 16, 2022 are entitled to notice of and to vote at the Meeting.
Whether or not you plan to
attend the Meeting, it is important that your shares be represented and voted at the Meeting. Accordingly, after reading the Notice of
Annual General Meeting of Shareholders and the Proxy Statement to be provided separately, please (i) vote online or (ii) mark, date, sign
and mail the enclosed proxy or voting instruction form as promptly as possible in the enclosed stamped envelope. If voting by mail, the
proxy must be received by our transfer agent at least 48 hours (or such shorter period as the Chairman of the Meeting may determine) prior
to the appointed time of the Meeting to be validly included in the tally of ordinary shares voted at the Meeting. An earlier deadline
may apply to receipt of your voting instruction form, if indicated therein. Detailed proxy voting instructions are provided both in the
Proxy Statement and on the enclosed proxy card and voting instruction form. In the alternative, shareholders who hold their shares in
street name may be able to utilize the control number appearing on their voting instruction form to submit their voting instruction to
their brokers, trustees or nominees by other means, if so indicated on their voting instruction form.
NeuroSense Therapeutics Ltd.